Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Full Dose Myfortic and Reduced Dose Neoral in Renal Transplant
NCT00434590Phase 4Terminated
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Mar 2007; status: terminated.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00434590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434590.